Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome

The hypoxaemia of hepatopulmonary syndrome, seen in severe chronic liver dysfunction, occurs as a result of precapillary pulmonary arterial dilatation and arteriovenous communications. These abnormalities contribute to the mismatch between ventilation and perfusion, and the right to left blood flow shunting. Nitric oxide (NO) is a powerful vasodilator concerned with the regulation of pulmonary vascular tone in man. Using a chemiluminescence analyser, we have measured endogenously produced NO in the exhaled air of three patients with the hepatopulmonary syndrome, six normoxaemic cirrhotic patients and six healthy volunteers. The subjects breathed NO-free air throughout the measurements. The molar rate of production of exhaled NO was raised almost threefold in the patients with hepatopulmonary syndrome compared with normal volunteers and with normoxaemic cirrhotic patients. Hypoxia per se, achieved in the normal volunteers by breathing a hypoxic gas mixture, reduced rather than increased the exhaled NO. One hepatopulmonary syndrome patient received an orthotopic liver transplant and achieved normoxaemia after 3 months. The exhaled NO also returned to normal. Increased pulmonary production of NO could contribute to the development of the hepatopulmonary syndrome.

This article has been cited by other articles:

				J.-L. Frossard, E. Schiffer, B. Cikirikcioglu, J. Bourquin, D. R. Morel, and C. M. Pastor Opposite regulation of endothelial NO synthase by HSP90 and caveolin in liver and lungs of rats with hepatopulmonary syndrome Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G864 - G870. [Abstract] [Full Text] [PDF]

				O. C. Ioachimescu, A. C. Mehta, and J. K. Stoller Hepatopulmonary syndrome following portopulmonary hypertension Eur. Respir. J., June 1, 2007; 29(6): 1277 - 1280. [Abstract] [Full Text] [PDF]

				D R Taylor, M W Pijnenburg, A D Smith, and J C D Jongste Exhaled nitric oxide measurements: clinical application and interpretation. Thorax, September 1, 2006; 61(9): 817 - 827. [Abstract] [Full Text] [PDF]

				ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005 Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 912 - 930. [Full Text] [PDF]

				R. Rodriguez-Roisin, M.J. Krowka, Ph. Herve, M.B. Fallon, and on behalf of the ERS Task Force Pulmonary-Hepatic Pulmonary-Hepatic vascular Disorders (PHD) Eur. Respir. J., November 1, 2004; 24(5): 861 - 880. [Full Text] [PDF]

				G. Rolla, L. Brussino, E. Scappaticci, M. Morello, R. Innarella, F. Rosina, and C. Bucca Source of Exhaled Nitric Oxide in Primary Biliary Cirrhosis Chest, November 1, 2004; 126(5): 1546 - 1551. [Abstract] [Full Text] [PDF]

				A.T. Dinh-Xuan and R. Naeije The hepatopulmonary syndrome: NO way out? Eur. Respir. J., May 1, 2004; 23(5): 661 - 662. [Full Text] [PDF]

				B. Luo, L. Liu, L. Tang, J. Zhang, Y. Ling, and M. B. Fallon ET-1 and TNF-{alpha} in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G294 - G303. [Abstract] [Full Text] [PDF]

				B. W. Duncan and S. Desai Pulmonary arteriovenous malformations after cavopulmonary anastomosis Ann. Thorac. Surg., November 1, 2003; 76(5): 1759 - 1766. [Abstract] [Full Text] [PDF]

				D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]

				C. DELCLAUX, B. MAHUT, F. ZERAH-LANCNER, C. DELACOURT, S. LAOUD, D. CHERQUI, C. DUVOUX, A. MALLAT, and A. HARF Increased Nitric Oxide Output from Alveolar Origin during Liver Cirrhosis versus Bronchial Source during Asthma Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 332 - 337. [Abstract] [Full Text] [PDF]

				P. Schenk, C. Madl, S. Rezaie-Majd, S. Lehr, and C. Muller Methylene Blue Improves the Hepatopulmonary Syndrome Ann Intern Med, November 7, 2000; 133(9): 701 - 706. [Abstract] [Full Text] [PDF]

				E. CLINI, G. CREMONA, M. CAMPANA, C. SCOTTI, M. PAGANI, L. BIANCHI, A. GIORDANO, and N. AMBROSINO Production of Endogenous Nitric Oxide in Chronic Obstructive Pulmonary Disease and Patients with Cor Pulmonale . Correlates with Echo-Doppler Assessment Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 446 - 450. [Abstract] [Full Text] [PDF]

				P. Silkoff Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children---1999 . THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY WAS ADOPTED BY THE ATS BOARD OF DIRECTORS, JULY 1999 Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2104 - 2117. [Full Text]

				N. Azzolin, E. Baraldi, S. Carra', G. Guariso, P. Zucchetta, and L. Zancan Exhaled Nitric Oxide and Hepatopulmonary Syndrome in a 6-Year-Old Child Pediatrics, August 1, 1999; 104(2): 299 - 300. [Full Text]

				K.-N. Lee, H.-J. Lee, W. W. Shin, and W. R. Webb Hypoxemia and Liver Cirrhosis (Hepatopulmonary Syndrome) in Eight Patients: Comparison of the Central and Peripheral Pulmonary Vasculature Radiology, May 1, 1999; 211(2): 549 - 553. [Abstract] [Full Text]

				A. THERMINARIAS, P. FLORE, A. FAVRE-JUVIN, M.-F. ODDOU, M. DELAIRE, and F. GRIMBERT Air Contamination with Nitric Oxide . Effect on Exhaled Nitric Oxide Response Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 791 - 795. [Abstract] [Full Text] [PDF]

				M. F. Chirpaz-Oddou, A. Favre-Juvin, P. Flore, J. Eterradossi, M. Delaire, F. Grimbert, and A. Therminarias Nitric oxide response in exhaled air during an incremental exhaustive exercise J Appl Physiol, April 1, 1997; 82(4): 1311 - 1318. [Abstract] [Full Text] [PDF]